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We present the perspective that lactate is a volume transmitter of cellular signals in brain
that acutely and chronically regulate the energy metabolism of large neuronal ensembles.
From this perspective, we interpret recent evidence to mean that lactate transmission
serves the maintenance of network metabolism by two different mechanisms, one by
regulating the formation of cAMP via the lactate receptor GPR81, the other by adjusting
the NADH/NAD+ redox ratios, both linked to the maintenance of brain energy turnover
and possibly cerebral blood ﬂow. The role of lactate as mediator of metabolic information
rather than metabolic substrate answers a number of questions raised by the controversial
oxidativeness of astrocytic metabolism and its contribution to neuronal function.
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Here, we present the perspective that lactate acts as a volume
transmitter in brain tissue by distributing cellular signals that are
relevant to the metabolic support of large neuronal ensembles.
We interpret recent evidence to mean that lactate transmission is
involved in themaintenance of network homeostasis by two differ-
ent mechanisms; one by regulation of neuronal cAMP formation
through the lactate receptor GPR81, the other by adjustment of
the NADH/NAD+ redox ratio. Lactate is an intermediary metabo-
lite in brain energy metabolism, the role of which is controversial
(Dienel, 2011). Traditionally, lactate was considered a waste prod-
uct with no certain function in the metabolic housekeeping when
eukaryotic cells have sufﬁcient oxygen. However, it is also held
to be a “preferred” substrate of energy metabolism, in muscle
(Brooks, 2009) as well as in brain (Bouzier-Sore et al., 2003; Smith
et al., 2003; Wyss et al., 2011). This alleged preference revives an
ancient claimof lactate’s service as nutrient for neurons that do not
phosphorylate glucose to the extent required by neuronal energy
metabolism (Andriezen, 1893; DiNuzzo et al., 2011). A cue to the
notion of a signaling role of lactate, irrespective of any role as
intermediary metabolite, is the observation that lactate regulates
cerebral blood ﬂow (Gordon et al., 2008).
VOLUME TRANSMISSION
The concept of volume transmission, introduced by Luigi Agnati
and Kjell Fuxe in 1986, designates is a form of communication in
brain tissue in which modulators act across wide distances when
their sites of release and removal are further apart than for “wired”
transmission, characteristic of focused synaptic action (Fuxe et al.,
2010). Volume transmission affects large volumes of tissue and
undergoes change more slowly than wired transmission. The con-
cept of volume transmission in brain therefore overlapswith forms
of paracrine and autocrine signaling. The canonical volume trans-
mitters aremonoamines, released fromvaricosities along the ﬁbers
of monoaminergic neurons and removed by transporters at sites
reached after variable distances of diffusion. However, the list of
potential agents of volume transmission is long, as any molecule
that engages receptors, transporters, or enzymes far from a place of
synthesis or release may qualify as a volume transmitter, including
the archetypical wired transmitter glutamate (Okubo and Iino,
2011). Another potential volume transmitter is L-DOPA, which
shares with lactate the ability to move across cellular membranes
and reach cells far from the sites of generation (Gjedde et al., 1993;
Ugrumov, 2009).
LACTATE RECEPTOR GPR81
The G-protein-coupled 7TM receptor (GPR) family includes
members that mediate speciﬁc actions of hydroxyl carboxylic
acids (HCA), including GPR81, also known as HCA1 recep-
tor (Blad et al., 2011), which serves lactate’s downregulation of
cAMP, as shown in adipocytes (Ahmed et al., 2009). The GPR81
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is prominent in adipose tissue, where it inhibits lipolysis, but it
is known also to be expressed in a wider range of organs such as
liver, kidney, skeletal muscle, spleen, and testis (Gantz et al., 1997;
Ge et al., 2008; Liu et al., 2009; Rooney and Trayhurn, 2011). Evi-
dence from in situ hybridization show a widespread distribution
of GPR81 mRNA in the brain, predominantly in neurons, includ-
ing the principal neurons in cortex, hippocampus (pyramidal
and granule cells), and cerebellum (granule cells), while label-
ing of astrocytes cannot be excluded (The Allen Institute for Brain
Science1, GENSTAT2, St. Jude Children’s Research Hospital3). The
receptor’s reported afﬁnities for L-lactate range from 1.3 to 5 mM
(Cai et al., 2008; Liu et al., 2009), which is consistent with the
range of lactate concentrations measured in brain tissue in vivo
(Abi-Saab et al., 2002). The binding of lactate to GPR81 attenu-
ates the formation of cAMP, which in turn inhibits protein kinase
A and hence glycogenolysis, leading to decreases of glucose-1-
phosphate and glucose-6-phosphate (G6P) that affect glycolysis
in the cytosol, as recently shown by kinetic modeling (DiNuzzo
et al., 2010). The decrease of G6P affects its role as allosteric
regulator of hexokinase (HK), including the association of HK
with the voltage dependent anion channel (VDAC) in the outer
mitochondrial membrane, with important consequences for the
efﬁciency of oxidative phosphorylation of ADP (Wilson, 2003;
Mailloux and Harper, 2011). The main thrust of this perspective
is the importance of any physical separation of HK and pyruvate
dehydrogenase (PDH) activities, which would lead to diffusion
of lactate between the sites. As such, this concept is not limited
to major compartments or cell types but applies equally well to
subdivisions of cells, such as distal vs proximal dendrites and
astrocytic processes vs cell bodies rather than to astrocyte/neuron
differences (Figure 1).
CYTOSOLIC AND MITOCHONDRIAL NADH/NAD+ REDOX
RATIOS AND LACTATE DEHYDROGENASES
Lactic and pyruvic acids interact through the actions of the cytoso-
lic near-equilibrium lactate dehydrogenase (LDH) isozymes,
which reﬂect the cytosolic NADH/NAD+ ratios in cytosol. The
cytosolic and the mitochondrial redox states are linked through
a network of redox reactions and inner membrane transport
processes, but the exact relation between cytosolic and mitochon-
drial NADH/NAD+ ratios is not known. There are reports of
mitochondrial LDH activity (Brooks, 2009) and therefore poten-
tial for coupling of lactate–pyruvate and NADH/NAD+ ratios in
the mitochondrial matrix. Changes of the NADH/NAD+ redox
ratios trigger several intracellular responses, including expres-
sion of genes by modiﬁcation of histone deacetylases, which
profoundly affect the regulation of protein synthesis. For exam-
ple sirtuins, gene-regulating histone deacetylases with effects on
regulation of caloric intake, metabolism and age-related dis-
eases (Finkel et al., 2009), are tightly redox regulated through the
NADH/NAD+ ratio (Gambini et al., 2011). Genes activated by
lactate through lactate-sensitive response elements include c-fos,
c-jun, c-ets, Hyal-1, Hyal-2, CD44, and caveolin-1 (Formby and
1http://www.brain-map.org
2http://www.ncbi.nlm.nih.gov/gensat
3http://www.stjudebgem.org
FIGURE 1 | In this illustration you can follow the two different
mechanisms proposed: (a) Lactate regulates the formation of cAMP via
the lactate receptor GPR81. (b) Lactate adjusts the NADH/NAD+ redox
ratio. (c) Both the formation of cAMP and the adjustment of NADH/NAD+
redox ratio can be linked to the maintenance of brain energy turnover and
neurovascular coupling. The role of lactate in neurovascular coupling is
included in the ﬁgure, but not dealt with in the text, which focuses on
cellular effects of lactate in brain tissue. The roles of lactate as mediator of
metabolic information rather than metabolic substrate answer a number of
questions raised by the aerobic glycolysis of astrocytes and its controversial
contribution to neuronal function.
Stern, 2003). The DNA binding of the transcription factor fos–
jun heterodimer AP-1 depends on a speciﬁc cysteine residue being
in the reduced sate (Abate et al., 1990), acting as a redox sen-
sor. In addition, pyruvate, which interacts closely with lactate as
dictated by the NADH/NAD+ ratio, is a gene regulator through
histone deacetylase inhibition (Thangaraju et al., 2009; Rajendran
et al., 2011).
NEAR-EQUILIBRIUM REACTIONS AND LACK OF
COMPARTMENTATION
Both the LDH isozymes and the monocarboxylic acid trans-
porters (MCT) of the blood–brain barrier and cell membranes of
brain tissue mediate near-equilibrium transfer of lactate (Berg-
ersen et al., 2001; Bergersen, 2007) when unidirectional ﬂuxes
exceed net ﬂuxes by several orders of magnitude. Therefore LDH
and MCT proteins serve to dissipate lactate concentration differ-
ences across cell membranes and tissue volumes. Thus, changes
of pyruvate and lactate concentrations in one place lead to similar
changes of lactate concentrations across large volumes of brain
tissue over long times. In turn, any effects of changes of lactate
on the NADH/NAD+ ratio in one place lead to similar effects
in widely distributed populations of cells (cf. Cerdán et al., 2006;
Ramírez et al., 2007; Rodrigues et al., 2009). In fact, the transfer
of lactate is so efﬁcient that it is difﬁcult to observe any differ-
ences of lactate concentrations across cell membranes in brain
tissue (Gjedde and Marrett, 2001; Ido et al., 2001, 2004; Gjedde
et al., 2002), such that signiﬁcant cellular compartmentation of
lactate is unlikely to exist under normal conditions, except brieﬂy.
The high concentration of MCT2 at the PSD of fast excitatory
synapses co-localized with glutamate receptors (Bergersen et al.,
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2001, 2005) suggests a particular need for lactate transfer at these
synapses perhaps involved in volume transmission signaling. In
addition to moving through brain tissue by facilitated transfer
across plasma membranes of all cells through MCT1, MCT2,
and MCT4, and by diffusion through the extracellular space, lac-
tate spreads through the astroglial network in which individual
astrocytes are connected by gap junctions (Dienel, 2011; Math-
iesen et al., 2011). One puzzle is the kinetic differences among the
isozymes of LDH (O’Brien et al., 2007), the physiological role of
which at near-equilibrium is not yet understood (Ross et al., 2010;
Quistorff and Grunnet, 2011; Ross, 2011), but may be related to
the proposed function of lactate as a volume transmitter in cytoso-
lic and perhaps mitochondrial environments with widely differing
NADH/NAD+ ratios (Figure 1).
NON-STEADY-STATES AND ACTIVATION
The purported changes of lactate concentrations and the conse-
quent redistribution of lactate happen whenever and wherever
sites of generation and metabolic conversion of pyruvate are
unmatched or physically separated. Pyruvate is the main end
product of aerobic glycolysis, which is controlled by the con-
certed action of the HK and phosphofructokinase (PFK) enzyme
complex, while the fate of pyruvate is determined by the PDH
complex in mitochondria. The two enzyme complexes are the
main ﬂux-generating determinants of brain energy metabolism
as controlled by allosteric effectors, and both therefore deﬁne the
path that is open to the respective so-called “pathway substrates,”
glucose in the case of the HK–PFK complex, pyruvate in the case
of the PDH complex (Gjedde, 2007). The temporal and spatial
integration of the activities of these enzyme complexes is then
the key to the dynamics of lactate inside and among the cells of
brain tissue. Both the oxygen–glucose index (OGI) and the oxygen
extraction fraction (OEF) decline during the temporary depar-
tures from steady-state associated with functional activation of
brain regions, attributed to increased aerobic glycolysis (Madsen
et al., 1999; Schmalbruch et al., 2002). The declines are signs of
focal disintegration of the HK–PFK and PDH activities, resulting
in increased lactate–pyruvate ratios, redistribution of lactate and
adjustment of NADH/NAD+ ratios within the sphere of action of
the redistributed lactate. This process seems to be so efﬁcient that
it leaves no oxygen deﬁcit or abnormal ATP, ADP, or AMP levels,
even in seizures (Larach et al., 2011).
Extracellular lactate concentrations increase during neuronal
and synaptic activation in vivo, as determined by microdialy-
sis (Uehara et al., 2008; Bero et al., 2011), and proton magnetic
resonance spectroscopy minutes after stimulation (Prichard et al.,
1991; Sappey-Marinier et al., 1992; Maddock et al., 2006), follow-
ing a transient decrease 5 s after stimulation (Mangia et al., 2003).
These observations are consistent with adjustments that follow
the perturbation of an existing steady-state and the subsequent
return to a potential new steady-state, depending on conditions,
such as the intensity of the continuing neuronal activation. The
lactate dynamics are uniquely dependent on the shifts among
these steady- and non-steady-states of brain energy metabolism.
The observations that the OGI declines during the non-steady-
state of the early stages of functional brain activation, signiﬁes
increased lactate production in the tissue as a whole, evidently due
to increased glucose consumption relative to oxygen consumption.
The observations are consistent with changes of glucose consump-
tion that match the changes of blood ﬂow during activation, while
changes of oxygen consumption generally do not (Gjedde et al.,
2002; Paulson et al., 2010). Recent evidence also shows that the
changes of glucose consumption exceed the changes of oxygen
consumption at speciﬁc regional locations (Vaishnavi et al., 2010),
rather than everywhere, creating the gradients of lactate concen-
tration that serve to redistribute lactate inside as well as outside
cells and across the blood–brain barrier. The regional variation of
theOGI (Vaishnavi et al., 2010)may possibly be related to different
ratios of cell types (low in cortex with numerous astrocytes, high
in cerebellum with numerous neurons). Any separation of the
sites of lactate generation and lactate metabolism inside or among
cells therefore must result in shuttling of lactate among its sites of
generation and metabolism. The ﬂuxes alter the interactions with
enzymes and transporters that qualify as volume transmission.
Thus, the temporal and spatial mismatches of lactate generation
and metabolism arise because different cellular and subcellular
compartments react differently to activating stimuli (Gjedde et al.,
2005; Vaishnavi et al., 2010).
CENTRAL vs PERIPHERAL FATIGUE
Physical exertion generates considerable increases of lactate con-
centration in the circulation. It has been shown by MR spec-
troscopy that blood lactate is an efﬁcient substrate for the brain,
and especially for neurons, both in rat (Bouzier et al., 2000; Has-
sel and Bråthe, 2000) and in humans (Boumezbeur et al., 2010).
The increased lactate also has effects on brain metabolism, which
are characterized by reduction of the cerebral OGI in the context
of a state known as “central fatigue” (Dalsgaard, 2006; Dalsgaard
and Secher, 2007; Rasmussen et al., 2010). Central fatigue pre-
cedes the muscle fatigue that also relates to increased lactate (van
Hall, 2010). The mechanism responsible for the onset of central
fatigue is not known with certainty but appears to be related to
decreased oxygen delivery, which in turn may be due to increased
lactate in brain tissue and possible effects on lactate’s receptor
GPR81 (Rasmussen et al., 2010; Gam et al., 2011). The down-
regulation of cAMP formation by binding of lactate to GPR81
offers a novel explanation of central fatigue and “over-training”
distress (Lehmann et al., 1993), and possibly in part the asthe-
nia seen in advanced cancer, a condition that is known to be
characterized by chronically increased blood lactate levels (Kop-
penol et al., 2011). Chronically increased lactate levels similarly
are held to be characteristic of old age and dementia, based on
the properties of a mtDNA mutator mouse model (Ross et al.,
2010). These effects contrast with the upregulation of cAMP by
noradrenaline with effects such as arousal and enhanced brain
performance (Berridge, 2008).
Many other observed effects of lactate on neuronal function
may result from enzyme- or receptor-mediated responses rather
than from the direct actions of lactate as a metabolic substrate.
For example, the observation that lactate administration pro-
tects against ischemia (Schurr et al., 1997, 2001; Cureton et al.,
2010) has been ascribed to enhanced neuronal energy turnover.
However, this is not readily explained by metabolic effects, as
lactate metabolism cannot raise energy turnover under ischemic
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conditions, although after ischemia and in the penumbra of vascu-
lar occlusion, the availability of lactate for oxidation may assist in
alleviating ischemia induced damage (Schurr et al., 2001; Berthet
et al., 2009). Similarly, the observed protective effect of lactate
on glutamate toxicity in the brain (Ros et al., 2001) may be due
to receptor-mediated inhibition, rather than the simple satis-
faction of the metabolic demands of neurons exposed to high
concentrations of glutamate (Schurr et al., 1999). In microdialy-
sis of the cerebral cortex, excitotoxic concentrations of glutamate
raised lactate at the expense of glucose in the dialysate. The
addition of L-lactate caused the lesion to become smaller and
abolished the decrease of glucose. Replacing L-lactate with the
non-physiological D-lactate isomer expanded the lesion and raised
L-lactate in the dialysate above the level observed with glutamate
alone (Ros et al., 2001), consistent with the claim that endoge-
nously produced lactate is neuroprotective by means of receptor
interaction.
The suppression of noradrenalin and adrenalin releases by
blood lactate clamps at 4 mM (Fattor et al., 2005) also suggests
a receptor mechanism, consistent with the postulated reduc-
tion of cAMP formation by GRP81 activation. Interestingly, also
β-adrenoceptor blockers, which presumably act by reducing intra-
cellular cAMP, are neuroprotective in stroke and other brain
injuries, and also lower extracellular glutamate levels, which may
further limit excitotoxic cell damage (Goyagi et al., 2011).
CONCLUSION
The proposed role of lactate as a mediator of information on
changing NADH/NAD+ ratios among the cells of brain tissue has
implications for the understanding of regulation of brain energy
metabolism, including the communication between cytosol and
mitochondria in large populations of cells (Xu et al., 2007). Lac-
tate’s inhibition of cAMP formation through G-protein-coupled
receptors may be a factor in the development of central fatigue.
An action of lactate may therefore be to “smooth” the non-steady-
states that underlie the mismatches of glycolysis and oxidative
phosphorylation, induced by needs for aerobic glycolysis that
satisfy the short time constants of ATP turnover required for
maintenance of rapid de- and repolarizations. The redistribution
of lactate by the volume transmission is both temporal and spa-
tial and potentially reaches large volumes of tissue, aided by the
extended syncytiumof astrocytic networks connected by gap junc-
tions. The role of lactate as informant of metabolic states rather
than substrate of metabolism solves a number of puzzles that
contribute to the controversy surrounding the understanding of
astrocytic metabolism and its contribution to neuronal function.
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